Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells

Berlak, Mareike; Tucker, Elizabeth; Dorel, Mathurin; Winkler, Annika; McGearey, Aleixandria; Rodriguez-Fos, Elias; da Costa, Barbara Martins; Barker, Karen; Fyle, Elicia; Calton, Elizabeth; Eising, Selma; Ober, Kim; Hughes, Deborah; Koutroumanidou, Eleni; Carter, Paul; Stankunaite, Reda; Proszek, Paula; Jain, Neha; Rosswog, Carolina; Dorado-Garcia, Heathcliff; Molenaar, Jan Jasper; Hubank, Mike; Barone, Giuseppe; Anderson, John; Lang, Peter; Deubzer, Hedwig Elisabeth; Kuenkele, Annette; Fischer, Matthias; Eggert, Angelika; Kloft, Charlotte; Henssen, Anton George; Boettcher, Michael; Hertwig, Falk; Bluthgen, Nils; Chesler, Louis; Schulte, Johannes Hubertus

Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells

Autor(en):

Berlak, Mareike; Tucker, Elizabeth; Dorel, Mathurin; Winkler, Annika; McGearey, Aleixandria; Rodriguez-Fos, Elias; da Costa, Barbara Martins; Barker, Karen; Fyle, Elicia; Calton, Elizabeth; Eising, Selma; Ober, Kim; Hughes, Deborah; Koutroumanidou, Eleni; Carter, Paul; Stankunaite, Reda; Proszek, Paula; Jain, Neha; Rosswog, Carolina; Dorado-Garcia, Heathcliff; Molenaar, Jan Jasper; Hubank, Mike; Barone, Giuseppe; Anderson, John; Lang, Peter; Deubzer, Hedwig Elisabeth; Kuenkele, Annette; Fischer, Matthias; Eggert, Angelika; Kloft, Charlotte; Henssen, Anton George; Boettcher, Michael; Hertwig, Falk; Bluthgen, Nils; Chesler, Louis; Schulte, Johannes Hubertus

Tübinger Autor(en):

Lang, Peter

Erschienen in:

Molecular Cancer (2022), Bd. 21 (1), Article 126

Verlagsangabe:

Bmc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1186/s12943-022-01583-z

ISSN:

1476-4598